Fractional CO2 Laser-Assisted Botulinum Toxin Type A Delivery for Primary Palmar Hyperhidrosis: A Case Report

Authors

  • Sarah Diba 3Department of Dermatology and Venereology, Faculty of Medicine, Sriwijaya University; Dr. Mohammad Hoesin General Hospital, Palembang, South Sumatera, Indonesia
  • Yuli Kurniawati Department of Dermatology and Venereology, Faculty of Medicine, Sriwijaya University; Dr. Mohammad Hoesin General Hospital, Palembang, South Sumatera, Indonesia
  • Odelia Jovita Jusuf Fantoni Department of Dermatology and Venereology, Faculty of Medicine, Sriwijaya University; Dr. Mohammad Hoesin General Hospital, Palembang, South Sumatera, Indonesia

Keywords:

Primary palmar hyperhidrosis, Laser-assisted drug delivery, Botulinum toxin type A, Fractional CO2 laser

Abstract

Primary palmar hyperhidrosis (PPH) can be challenging for both patient and physician. Botulinum toxin type A (BTX-A)injection has been shown to be useful in treating PPH, whilst it causes pain and discomfort in most of the patient. Herein, we report a male patient with PPH who had shown a promising outcome after being treated with fractional CO2 laser-assisted BTX-Adelivery with no adverse effects.

References

Parhi R, Mandru A. Enhancement of skin permeability with thermal ablation techniques: Concept to commercial products. Drug Deliv Transl Res. 2020;1-25.

Chow A, Wilder-Smith EP. Effect of transdermal botulinum toxin on sweat secretion in subjects with idiopathic palmar hyperhidrosis. Br J Dermatol. 2009;160(3):721–2.

Braun SA, Schrumpf H, Buhren BA, Homey B, Gerber PA. Laser-assisted drug delivery: Mode of action and use in daily clinical practice. J Dtsch Dermatol Ges. 2016;14(5):480–9.

Zaleski-Larsen LA, Fabi SG. Laser-assisted drug delivery. Dermatol Surg. 2016;42(8):919–31.

Hsiao CY, Yang SC, Alalaiwe A, Fang JY. Laser ablation and topical drug delivery: A review of recent advances. Expert Opinion on Drug Delivery. 2019;16(9):937–52.

Hexsel D. Botulinum Toxins. In: Barran R, Maibach HI, editors. Textbook of Cosmetic Dermatology. 5th ed. New York: CRC Press; 2017. p. 459–72.

Glogau RG. Botulinum Toxin. In: Kang S, Amagai M, Bruckner AL, Margolis DJ, McMichael AJ, Orringer JS, editors. Fitzpatrick’s Dermatology. 9th ed. New York: McGraw Hill Companies; 2019. p. 3921–30.

Singh BR, Kukreja R. The botulinum toxin as a therapeutic agent: Molecular and pharmacological insights. Research and Reports in Biochemistry. 2015;5:173-83.

Sklar LR, Burnett CT, Waibel JS, Moy RL, Ozog DM. Laser assisted drug delivery: A review of an evolving technology. Lasers Surg Med. 2014;46(4):249–62.

Junsuwan N, Manuskiatti W, Phothong W, Wanitphakdeedecha R. Fractional CO2 laser-assisted Botulinum toxin type A delivery for the treatment of primary palmar hyperhidrosis. Lasers Med Sci. 2020;1–3.

Lin CH, Aljuffali IA, Fang JY. Lasers as an approach for promoting drug delivery via skin. Expert Opin Drug Deliv. 2014;11(4):599–614.

Carruthers A, Carruthers J, de Almeida AT. Botulinum Toxin. In: Bolognia JL, Schaffer J V, Cerroni L, editors. Dermatology. 4th ed. New York: Elsevier; 2018. p. 2661–72.

Downloads

Published

2023-10-12

How to Cite

1.
Diba S, Kurniawati Y, Fantoni OJJ. Fractional CO2 Laser-Assisted Botulinum Toxin Type A Delivery for Primary Palmar Hyperhidrosis: A Case Report. J Pak Assoc Dermatol [Internet]. 2023Oct.12 [cited 2024Dec.2];33(4):1677-80. Available from: https://www.jpad.com.pk/index.php/jpad/article/view/2295

Issue

Section

Case Reports

Most read articles by the same author(s)